Loading...
OTCMMDCE
Market cap5mUSD
Dec 24, Last price  
0.00USD
1D
6.90%
1Q
29.17%
Jan 2017
1,450.00%
IPO
121.43%
Name

Medical Care Technologies Inc

Chart & Performance

D1W1MN
OTCM:MDCE chart
P/E
P/S
7.01
EPS
Div Yield, %
0.00%
Shrs. gr., 5y
413.16%
Rev. gr., 5y
%
Revenues
732k
-78.90%
00000000003,469,685731,971
Net income
-388k
L
-37,543-55,742-85,121-1,940,207-1,923,887-2,763,311-4,358,7010001,099,465-387,506
CFO
30k
-78.56%
-32,969-21,050-82,050-134,135-371,920-245,142000139,54729,912

Profile

Medical Care Technologies Inc., a development stage company, engages in opening and operating children's integrated health and wellness centers in China. The company sells and distributes pharmaceutical and nutraceutical products, and other merchandise, including over-the-counter medicines, herbal products, personal care products, and family care products. It serves retail pharmacies, pharmaceutical companies, hospitals, physicians' office practices, and consumers; and industrial and food microbiology laboratories. The company offers its products through its pediatric health and wellness centers, Website, and retail pharmacies, as well as through sales and distribution channels, and directly to end-users through independent sales representatives. Medical Care Technologies Inc. was founded in 2007 and is headquartered in Beijing, China.
IPO date
Jul 23, 2012
Employees
Domiciled in
HK
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑12
Income
Revenues
732
-78.90%
3,470
 
Cost of revenue
1,113
2,139
Unusual Expense (Income)
NOPBT
(381)
1,330
NOPBT Margin
38.34%
Operating Taxes
(228)
Tax Rate
NOPAT
(381)
1,559
Net income
(388)
-135.24%
1,099
 
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
39
28
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
4
16
Cash flow
Cash from operating activities
30
140
CAPEX
Cash from investing activities
Cash from financing activities
(6)
(128)
FCF
19
621
Balance
Cash
35
12
Long term investments
Excess cash
Stockholders' equity
(10,778)
(10,391)
(11,492)
Invested Capital
11,351
11,340
11,492
ROIC
13.65%
ROCE
140.12%
EV
Common stock shares outstanding
3,209,575
3,209,575
2,959,575
Price
0.00
-28.57%
0.00
-82.77%
0.02
8,025.00%
Market cap
6,419
-28.57%
8,987
-81.31%
48,093
8,025.00%
EV
6,423
9,003
48,093
EBITDA
(381)
1,330
EV/EBITDA
6.77
Interest
6
Interest/NOPBT